Quest Diagnostics, Inc. (DGX)

Precedente Chiudi:

$138.18

Aprire:

$138.31

Volume 24 ore:

668.21K

Capitalizzazione di mercato:

$15.28B

Reddito:

$9.29B

Utile/perdita netta:

$846.00M

Rapporto P/E:

20.65

EPS:

6.66

Flusso di cassa netto:

$947.00M

1 W Prestazione:

+0.00%

1M Prestazione:

+2.06%

6M Prestazione:

+3.79%

1 anno Prestazione:

-1.38%

Intervallo 1D:

$136.47

$138.41

Portata 52W:

$119.59

$145.58

Quest Diagnostics, Inc. Stock (DGX) Company Profile

Nome

Quest Diagnostics, Inc.

Settore

Healthcare (1189)

Industria

Diagnostics & Research (66)

Telefono

973 520 2700

Indirizzo

500 Plaza Drive, Secaucus

Dipendente

45,000

Cinguettio

@QuestDX

Prossima data di guadagno

2024-05-16

Ultimi documenti SEC

DGX's Discussions on Twitter

Quest Diagnostics, Inc. Stock (DGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2024-01-03	Iniziato	Barclays	Equal Weight
2023-12-12	Aggiornamento	BofA Securities	Neutral → Buy
2023-06-29	Iniziato	Piper Sandler	Neutral
2023-05-02	Downgrade	BofA Securities	Buy → Neutral
2023-04-03	Aggiornamento	Citigroup	Sell → Neutral
2023-01-23	Iniziato	Evercore ISI	In-line
2022-11-17	Downgrade	Citigroup	Neutral → Sell
2022-08-22	Ripresa	Morgan Stanley	Equal-Weight
2022-04-04	Downgrade	Citigroup	Buy → Neutral
2022-02-23	Downgrade	UBS	Buy → Neutral
2022-02-02	Downgrade	Jefferies	Buy → Hold
2022-01-28	Downgrade	Deutsche Bank	Buy → Hold
2021-05-04	Aggiornamento	UBS	Neutral → Buy
2021-03-12	Downgrade	Robert W. Baird	Outperform → Neutral
2020-10-21	Aggiornamento	Argus	Hold → Buy
2020-07-29	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Aggiornamento	BofA Securities	Neutral → Buy
2020-06-09	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2020-06-02	Aggiornamento	Deutsche Bank	Hold → Buy
2020-04-28	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Aggiornamento	Citigroup	Neutral → Buy
2020-04-27	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2020-03-27	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Downgrade	Barclays	Overweight → Equal Weight
2019-12-19	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-07-15	Downgrade	Goldman	Neutral → Sell
2019-04-02	Aggiornamento	Jefferies	Hold → Buy
2019-03-18	Ripresa	Credit Suisse	Neutral
2019-01-31	Downgrade	Argus	Buy → Hold
2019-01-17	Iniziato	UBS	Neutral
2019-01-03	Downgrade	BofA/Merrill	Neutral → Underperform
2018-12-03	Downgrade	BofA/Merrill	Buy → Neutral
2018-11-30	Downgrade	Goldman	Buy → Neutral

Mostra tutto

Quest Diagnostics, Inc. Borsa (DGX) Ultime notizie

The Analyst Landscape: 5 Takes On Quest Diagnostics

Benzinga

Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic

Benzinga

Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down

Zacks Investment Research

Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates

Zacks Investment Research

Unlocking Q1 Potential of Quest Diagnostics (DGX): Exploring Wall Street Estimates for Key Metrics

Zacks Investment Research

US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory'

Benzinga

Quest Diagnostics, Inc. Azioni (DGX) Dati Finanziari

Quest Diagnostics, Inc. (DGX) Reddito 2024

Quest Diagnostics, Inc. (DGX) Reddito netto 2024

Quest Diagnostics, Inc. (DGX) Flusso di cassa 2024

Quest Diagnostics, Inc. (DGX) Utile per azione 2024

Quest Diagnostics, Inc. Azioni (DGX) insider trading